- Home
- IMCC vs ADIL Comparison
IMCC vs ADIL Comparison
Compare IMCC & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- ADIL
- Stock Information
- Founded
- IMCC 1980
- ADIL 2010
- Country
- IMCC Israel
- ADIL United States
- Employees
- IMCC N/A
- ADIL N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- ADIL Health Care
- Exchange
- IMCC Nasdaq
- ADIL Nasdaq
- Market Cap
- IMCC 5.3M
- ADIL 4.3M
- IPO Year
- IMCC N/A
- ADIL 2018
- Fundamental
- Price
- IMCC $1.66
- ADIL $0.66
- Analyst Decision
- IMCC
- ADIL Strong Buy
- Analyst Count
- IMCC 0
- ADIL 1
- Target Price
- IMCC N/A
- ADIL $8.00
- AVG Volume (30 Days)
- IMCC 11.4K
- ADIL 1.7M
- Earning Date
- IMCC 05-15-2025
- ADIL 05-15-2025
- Dividend Yield
- IMCC N/A
- ADIL N/A
- EPS Growth
- IMCC N/A
- ADIL N/A
- EPS
- IMCC N/A
- ADIL N/A
- Revenue
- IMCC $37,894,737.00
- ADIL N/A
- Revenue This Year
- IMCC $47.12
- ADIL N/A
- Revenue Next Year
- IMCC $12.83
- ADIL N/A
- P/E Ratio
- IMCC N/A
- ADIL N/A
- Revenue Growth
- IMCC 12.68
- ADIL N/A
- 52 Week Low
- IMCC $1.29
- ADIL $0.58
- 52 Week High
- IMCC $5.10
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- IMCC 53.36
- ADIL 47.36
- Support Level
- IMCC $1.56
- ADIL $0.57
- Resistance Level
- IMCC $1.71
- ADIL $0.68
- Average True Range (ATR)
- IMCC 0.17
- ADIL 0.10
- MACD
- IMCC 0.01
- ADIL -0.00
- Stochastic Oscillator
- IMCC 55.32
- ADIL 13.72
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.